| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $70.9M | — | +35.1% |
| Cost of Revenue | $18.7M | — | +10.2% |
| R&D Expense | $23.6M | — | -2.4% |
| SG&A Expense | $21.0M | — | +20.6% |
| Operating Income | -$19.2M | — | +35.1% |
| Interest Expense | $2.9M | — | -0.6% |
| Net Income | -$20.0M | — | +32.9% |
| EPS (Basic) | -$0.13 | — | +35.0% |
| EPS (Diluted) | -$0.13 | — | +35.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $77.6M | +10.1% | +53.2% |
| Accounts Receivable | $48.3M | -4.1% | +10.9% |
| Inventory | $11.2M | +14.1% | +29.0% |
| Current Assets | $291.8M | -2.8% | +13.8% |
| Total Assets | $505.9M | -1.3% | -1.0% |
| Current Liabilities | $87.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.5M | — | +66.5% |
| Capital Expenditures | $796K | — | -36.8% |
| Investing Cash Flow | $9.1M | — | -64.2% |
| Financing Cash Flow | $7.5M | — | +37.6% |
| Free Cash Flow | -$10.3M | — | +65.3% |
| -0.9% |
| Long-term Debt | $124.7M | -1.4% | -5.2% |
| Total Liabilities | $281.7M | -2.1% | -12.1% |
| Stockholders' Equity | $216.3M | -1.1% | +13.6% |